TrialInternational clinical psychopharmacology2016

Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia.

Bennett Levitan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.